Cargando…

Immunotherapy and Immune Evasion in Prostate Cancer

Metastatic prostate cancer remains to this day a terminal disease. Prostatectomy and radiotherapy are effective for organ-confined diseases, but treatment for locally advanced and metastatic cancer remains challenging. Although advanced prostate cancers treated with androgen deprivation therapy achi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thakur, Archana, Vaishampayan, Ulka, Lum, Lawrence G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730318/ https://www.ncbi.nlm.nih.gov/pubmed/24216992 http://dx.doi.org/10.3390/cancers5020569

Ejemplares similares

Phase I Study of Anti-CD3 x Anti-Her2 Bispecific Antibody in Metastatic Castrate Resistant Prostate Cancer Patients
por: Vaishampayan, Ulka, et al.
Publicado: (2015)

Development of cabozantinib for the treatment of prostate cancer
por: Vaishampayan, Ulka N
Publicado: (2014)

Overcoming Obstacles in Liquid Biopsy Developments for Prostate Cancer
por: Jang, Albert, et al.
Publicado: (2022)

Immune landscape of human prostate cancer: immune evasion mechanisms and biomarkers for personalized immunotherapy
por: Bou-Dargham, Mayassa J., et al.
Publicado: (2020)

Immune disorder in endometrial cancer: Immunosuppressive microenvironment, mechanisms of immune evasion and immunotherapy
por: Zhan, Lei, et al.
Publicado: (2020)

Immune Evasion as the Main Challenge for Immunotherapy of Cancer
por: Zagozdzon, Radoslaw, et al.
Publicado: (2022)

In Situ immunization by bispecific antibody targeted T cell therapy in breast cancer
por: Thakur, Archana, et al.
Publicado: (2015)

The Year in Review for Renal Cancer
por: Vaishampayan, Ulka
Publicado: (2020)

The power of meta-analysis in therapeutic decision making for advanced kidney cancer
por: Vaishampayan, Ulka
Publicado: (2019)

Next frontier in tumor immunotherapy: macrophage-mediated immune evasion
por: Qiu, Yingqi, et al.
Publicado: (2021)

Current State of Immunotherapy and Mechanisms of Immune Evasion in Ewing Sarcoma and Osteosarcoma
por: Evdokimova, Valentina, et al.
Publicado: (2022)

hrHPV E5 oncoprotein: immune evasion and related immunotherapies
por: de Freitas, Antonio Carlos, et al.
Publicado: (2017)

The Role of Metabolism in Tumor Immune Evasion: Novel Approaches to Improve Immunotherapy
por: Cruz-Bermúdez, Alberto, et al.
Publicado: (2021)

Exceptional pathologic complete response achieved with androgen deprivation and docetaxel therapy in Gleason 10 prostate cancer
por: Vaishampayan, Ulka, et al.
Publicado: (2019)

Immune Modulation by Androgen Deprivation and Radiation Therapy: Implications for Prostate Cancer Immunotherapy
por: Kalina, Jennifer L., et al.
Publicado: (2017)

Nanotechnology-Based siRNA Delivery Systems to Overcome Tumor Immune Evasion in Cancer Immunotherapy
por: Deng, Kaili, et al.
Publicado: (2022)

Can Immune Suppression and Epigenome Regulation in Placenta Offer Novel Insights into Cancer Immune Evasion and Immunotherapy Resistance?
por: Hossain, Sultana Mehbuba, et al.
Publicado: (2021)

Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells
por: Urbanska, Katarzyna, et al.
Publicado: (2014)

Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy
por: de Charette, Marie, et al.
Publicado: (2018)

Mechanism of immune evasion in breast cancer
por: Wang, Mozhi, et al.
Publicado: (2017)

Mechanisms of immune evasion in bladder cancer
por: Crispen, Paul L., et al.
Publicado: (2019)

Immune evasion by cancer stem cells
por: Tsuchiya, Hiroyuki, et al.
Publicado: (2021)

Predictors of Cytoreductive Nephrectomy for Metastatic Kidney Cancer in SEER and Metropolitan Detroit Databases
por: Vaishampayan, Ulka, et al.
Publicado: (2019)

Immune T cells can transfer and boost anti-breast cancer immunity
por: Thakur, Archana, et al.
Publicado: (2018)

Perception of cure among patients with metastatic genitourinary cancer initiating immunotherapy
por: Bergerot, Cristiane Decat, et al.
Publicado: (2019)

Immune evasion strategies of neuroendocrine-like Enzalutamide resistant prostate cancer
por: Bishop, Jennifer L, et al.
Publicado: (2013)

Filoviral Immune Evasion Mechanisms
por: Ramanan, Parameshwaran, et al.
Publicado: (2011)

Lymphoma: Immune Evasion Strategies
por: Upadhyay, Ranjan, et al.
Publicado: (2015)

Overcoming Immune Evasion in Melanoma
por: Eddy, Kevinn, et al.
Publicado: (2020)

Immune Evasion of Mycoplasma bovis
por: Askar, Hussam, et al.
Publicado: (2021)

Evasion of the Host Immune Response by Betaherpesviruses
por: Sausen, Daniel G., et al.
Publicado: (2021)

Identification and Validation of an Immune Evasion Molecular Subgroup of Patients With Colon Cancer for Implications of Immunotherapy
por: Zhang, Hongbin, et al.
Publicado: (2022)

Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer
por: Lee, Joyce V., et al.
Publicado: (2022)

Synergistic effect of glutathione and IgG4 in immune evasion and the implication for cancer immunotherapy()
por: Zhang, Weifeng, et al.
Publicado: (2023)

Current understanding of cancer stem cells: Immune evasion and targeted immunotherapy in gastrointestinal malignancies
por: An, Junyi, et al.
Publicado: (2023)

DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancers
por: Pineda, Jose Mario Bello, et al.
Publicado: (2023)

CD8(+) T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy
por: Pourchet, Aldo, et al.
Publicado: (2016)

Beyond the Immune Suppression: The Immunotherapy in Prostate Cancer
por: Silvestri, Ida, et al.
Publicado: (2015)

Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate Cancer
por: Ogita, Shin, et al.
Publicado: (2012)

Immune Evasion in Pancreatic Cancer: From Mechanisms to Therapy
por: Martinez-Bosch, Neus, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2gacbh2mmb6vra6v8h80vcul48